Abstract
Synthetic approaches to a new class of tyrosine-linked prodrugs of two 3-hydroxy-2-(phosphonomethoxypropyl) (HPMP) nucleotide analogues [(S)-HPMPC and (S)-HPMPA] are outlined.
Acknowledgments
This work was supported by grants AI061457 and AI056864 from the National Institutes of Health.